Status:
COMPLETED
Clinical Efficacy of Conservative Treatment in Female Patients With Plevic Congestion Syndrome
Lead Sponsor:
Interregional Clinical Diagnostic Center, Russia
Conditions:
Pelvic Congestion Syndrome
Eligibility:
FEMALE
18-60 years
Brief Summary
The article presents the results of a randomized, placebo-controlled study of the conservative treatment with Daflon (Detralex) in female patients with Pelvic congestion syndrome .
Eligibility Criteria
Inclusion
- •The presence of pelvic varicose veins verified by transvaginal and transabdominal duplex ultrasound scanning
Exclusion
- Severe disease of the gastrointestinal tract or hematopoietic system
- Terminal stage of cardiovascular, respiratory, renal or hepatic failure
- Grade IV malignancy
- Peripheral artery disease (PAD) of the lower extremities, any type of diabetes, or mental disease.
- Pregnant women at any gestational age, women who gave birth less than 12 months ago, and breastfeeding mothers.
Key Trial Info
Start Date :
December 28 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 28 2020
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT04512443
Start Date
December 28 2019
End Date
March 28 2020
Last Update
August 13 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Akhmetzianov Rustem
Kazan', Russia, 420097
2
Roman Bredikhin
Kazan', Russia